Zenas BioPharma, Inc. Financial Overview
Zenas BioPharma, Inc.'s market cap is currently $2.27B. The company's EPS TTM is $-3.899; its P/E ratio is -9.45; Zenas BioPharma, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
